#USA #Miami #PM360 Awards #PharmaForceIQ #Optichannel 360

PharmaForceIQ's Success at PM360 Innovation Awards 2026

PharmaForceIQ recently celebrated a significant achievement when its groundbreaking platform, Optichannel 360, was named a winner at the prestigious PM360 Innovation Awards 2026. This annual event showcases the most innovative ideas and technologies in the pharmaceutical industry, recognizing advancements that promise to enhance practices and patient outcomes.

The Optichannel 360 platform, designed to unify brand marketing and sales execution for pharmaceutical companies, leverages an AI-native framework. This innovative approach allows for the coordination of marketing strategies across diverse channels, ensuring a seamless integration of digital and field engagements which have historically been managed separately.

A New Era in Pharmaceutical Marketing

PharmaForceIQ's Chief Executive and Strategy Officer, Hemal Somaiya, expressed the transformative potential of Optichannel 360, stating, "By merging field sales with digital marketing under one cohesive model, our platform enables commercial leaders to swiftly convert real-time data signals into actionable insights across all channels." With a deployment across over 100 brands, the award serves as a testament to their vision of revolutionizing pharma marketing.

The platform employs PharmaForceIQ's Affinity Intelligence, which processes over 100 million live preference signals tied to approximately 7 million National Provider Identifiers (NPIs). This capability allows healthcare professionals' preferences to be accurately mapped, tailoring content, channels, and messaging to suit individual needs. Through this bespoke approach, Optichannel 360 can suggest personalized and automated interactions across an extensive network of over 75,000 endpoints, thus enhancing engagement efficiency.

Embracing the Future with Advanced Insights

Key enhancements introduced in 2026 include the addition of Knowledge Nexus, a comprehensive database comprising more than 100 million data points that have been collectively amassed over a decade of global field orchestration. This advanced analytics engine was further enhanced through PharmaForceIQ's acquisition of Aktana, a leader in field orchestration, which has significantly bolstered the platform’s capabilities.

The launch of the unified platform in August 2026 marked a notable milestone, introducing the first packaged agentic AI capability for pharma commercial teams. This feature promotes a measurement-focused, answer-to-action workflow that allows teams to probe into performance metrics, comprehend underlying factors, and incorporate approved next steps directly into ongoing campaign execution.

Acknowledgment of Game-Changing Innovations

The PM360 Innovation Awards highlight 18 transformative innovations from hundreds of submissions, showcasing what industry experts deem as game-changers. Optichannel 360’s recognition in the Marketing Technology or Services category spotlights its groundbreaking contribution to the field, indicating a shift towards a more integrated future in pharmaceutical marketing.

For further information on how Optichannel 360 is set to redefine brand strategy, measurement, and field representative workflow in the pharmaceutical industry, visit pharmaforceiq.com.

About PharmaForceIQ

PharmaForceIQ is committed to delivering precision customer engagement solutions tailored for the life sciences sector. Offering comprehensive end-to-end SaaS products and strategic services, the company strives to empower pharmaceutical leaders with efficient platforms designed to effectively engage healthcare professionals and patient audiences throughout the product lifecycle.